Table of Content

1. Market Definition & Scope
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency and Limitation
1.4. Key Stakeholders

2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Factor Analysis
4.3. Market Trends
4.3.1. Use of Hybrid Systems
4.3.2. Rising Focus on Continuous Bioprocessing
4.3.3. Shift Toward Bioprocessing 4.0
4.3.4. Integration of AI in Bioprocessing
4.4. Parent Market Analysis: Biopharmaceutical Processing Equipment and Consumables Market

5. Single-use Bioreactors Market Assessment?by Product
5.1. Overview
5.2. Single-use Bioreactor Systems
5.2.1. Upto 10 Liters Single-use Bioreactor Systems
5.2.2. 11–500 Liters Single-use Bioreactor Systems
5.2.3. 501–1000 Liters Single-use Bioreactor Systems
5.2.4. Above 1001 Liters Single-use Bioreactor Systems
5.3. Media Bags
5.3.1. 2D Media Bags
5.3.2. 3D Media Bags
5.3.3. Linear Media Bags
5.4. Filtration Assemblies
5.5. Other Products

6. Single-use Bioreactors Market Assessment?by Type
6.1. Overview
6.2. Stirred-tank Bioreactors
6.3. Wave-induced Bioreactors
6.4. Other Single-use Bioreactors

7. Single-use Bioreactors Market Assessment?by Cell Type
7.1. Overview
7.2. Mammalian Cells
7.3. Bacterial Cells
7.4. Yeast Cells
7.5. Other Cells

8. Single-use Bioreactors Market Assessment?by Application
8.1. Overview
8.2. Commercial Bioproduction
8.2.1. Monoclonal Antibody Production
8.2.2. Therapeutic Protein Production
8.2.3. Vaccine Production
8.2.4. Cell And Gene Therapy
8.3. Research Bioproduction

9. Single-use Bioreactors Market Assessment?by End User
9.1. Overview
9.2. Pharmaceutical And Biopharmaceutical Companies
9.3. Contract Development and Manufacturing Organizations & Contract Research Organizations
9.4. Academic & Research Institutes

10. Single-use Bioreactors Market Assessment?by Geography
10.1. Overview
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. U.K.
10.3.4. Italy
10.3.5. Switzerland
10.3.6. Spain
10.3.7. Ireland
10.3.8. Denmark
10.3.9. Belgium
10.3.10. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. India
10.4.3. Japan
10.4.4. South Korea
10.4.5. Rest of Asia-Pacific (RoAPAC)
10.5. Latin America
10.6. Middle East & Africa

11. Competition Analysis
11.1. Introduction
11.2. Key Growth Strategies
11.3. Vendor Benchmarking
11.4. Competitive Dashboard
11.4.1. Industry Leaders
11.4.2. Market Differentiators
11.4.3. Vanguards
11.4.4. Emerging Companies

12. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis of Top 5 Companies)
12.1. Thermo Fisher Scientific Inc.
12.2. Danaher Corporation
12.3. Merck KGaA
12.4. Eppendorf AG
12.5. Sartorius AG
12.6. Solaris Biotechnology Srl (A Subsidiary Of Donaldson Company, Inc.)
12.7. Cellexus International Ltd.
12.8. CESCO Bioengineering Co., Ltd.
12.9. Distek, Inc.
12.10. Infors AG
12.11. PBS Biotech, Inc.

13. Appendix
13.1. Available Customization
13.2. Related Reports



List of Figures

List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for This Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Single-use Bioreactors Market, by Product, 2023 Vs. 2030 (USD Million)
Figure 8 Global Single-use Bioreactors Market, by Type, 2023 Vs.2030 (USD Million)
Figure 9 Global Single-use Bioreactors Market, by Cell Type, 2023 Vs. 2030 (USD Million)
Figure 10 Global Single-use Bioreactors Market, by Application, 2023 Vs.2030 (USD Million)
Figure 11 Global Single-use Bioreactors Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 12 Global Single-use Bioreactors Market, by Geography
Figure 13 Impact Analysis: Single-use Bioreactors Market
Figure 14 Global Prescription Drug Sales, 2014–2028 (USD Billion)
Figure 15 Global Pharmaceutical R&D Spend, 2014–2028 (USD Billion)
Figure 16 Number of Biosimilars Approved in the U.S. and EU, 2014–2022
Figure 17 Global Geriatric Population (Aged 60 Years & Above), 2019–2050
Figure 18 Global Biopharmaceutical Processing Equipment and Consumables Market Size, 2022 Vs. 2029 (USD Million)
Figure 19 Global Single-use Bioreactors Market, by Product, 2023–2030 (USD Million)
Figure 20 Global Single-use Bioreactors Market, by Type, 2023–2030 (USD Million)
Figure 21 Global Single-use Bioreactors Market, by Cell Type, 2023–2030 (USD Million)
Figure 22 Global Single-use Bioreactors Market, by Application, 2023–2030 (USD Million)
Figure 23 Vaccine Projects in the Pipeline: 2020
Figure 24 Vaccine Doses: 2019 and 2021 (In Billion)
Figure 25 Number of Proteins Approved by FDA: 2017-2021
Figure 26 Global Single-use Bioreactors Market, by End User, 2023–2030 (USD Million)
Figure 27 Global Pharmaceutical R&D Spend (USD Billion)
Figure 28 Global Single-use Bioreactors Market, by Geography, 2023 Vs. 2030 (USD Million)
Figure 29 North America: Single-use Bioreactors Market Snapshot
Figure 30 Europe: Single-use Bioreactors Market Snapshot
Figure 31 Asia-Pacific: Single-use Bioreactors Market Snapshot
Figure 32 Key Growth Strategies Adopted by Leading Players, 2021–2023
Figure 33 Single-use Bioreactors Market: Vendor Benchmarking, by Product
Figure 34 Single-use Bioreactors Market: Vendor Benchmarking, by Region
Figure 35 Competitive Dashboard: Single-use Bioreactors Market
Figure 36 Thermo Fisher Scientific Inc.: Financial Overview (2022)
Figure 37 Danaher Corporation: Financial Overview (2022)
Figure 38 Merck KGaA: Financial Overview (2022)
Figure 39 Eppendorf AG: Financial Overview (2021)
Figure 40 Sartorius AG: Financial Overview (2022)